₹ 14868 / 14 Shares Shares
Minimum Investment
₹1008-1062 per equity share
08 Dec 2025
10 Dec 2025
14
₹ 14868
₹1008-1062
15 Dec 2025
61,71,101 shares(aggregating up to ₹655.37 crore)
₹10 Per Equity Share
14 Shares
14 Shares
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
2004
Dr. Kirtikumar Laxmidas Mehta
Corona Remedies Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹1008-1062 | ₹14,868 |
| Retail(max) | ₹1008-1062 | ₹1,93,284 |
| SHNI(min) | ₹1008-1062 | ₹2,08,152 |
| SHNI(max) | ₹1008-1062 | ₹9,96,156 |
| BHNI(min) | ₹1008-1062 | ₹10,11,024 |
For Corona Remedies Limited IPO, eligible investors can apply as Regular.
In case of default, the lender may sell pledged mutual fund units. KSquare advises timely repayment to avoid any financial impact.
Once documents are verified, the loan is usually disbursed within 24–48 hours directly to your bank account.
Interest rates vary by lender and profile, but KSquare offers competitive rates starting as low as 9% annually with minimal processing fees.
Yes, KSquare allows you to modify or increase your SIP contributions easily as your income or goals change.
Yes, KSquare’s digital platform allows you to browse, select, and invest in mutual funds entirely online.
Yes, KSquare builds dedicated SIP plans focused on medical security so unexpected health expenses don’t affect regular finances.
You’ll need KYC-compliant documents like PAN, Aadhaar, and bank details to invest in NFOs through KSquare.
Unlike existing funds with track records, NFOs offer fresh investment opportunities, often at a face value of ₹10.